XML 107 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Notes to the consolidated financial statements - Summary of upfront payments and related revenues recognized (Details) € in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023 EUR (€)	Dec. 31, 2022 EUR (€)	Dec. 31, 2021 EUR (€)	Dec. 31, 2023 USD ($)	Jul. 31, 2020 EUR (€)
Notes to the Consolidated Statements of Operations
Upfront and milestones payments included in contract liabilities	€ 92,680	€ 107,308
Revenue recognized from upfront and milestones payments	31,051	44,787	€ 67,828
GSK
Notes to the Consolidated Statements of Operations
Upfront Payments Received Or Receivable	220,000				€ 120,000
Upfront and milestones payments included in contract liabilities	88,715	102,804
Revenue recognized from upfront and milestones payments	29,089	42,690	51,728
Boehringer Ingelheim
Notes to the Consolidated Statements of Operations
Upfront Payments Received Or Receivable	30,000
Revenue recognized from upfront and milestones payments			14,003
Genmab
Notes to the Consolidated Statements of Operations
Upfront Payments Received Or Receivable	8,937			$ 10,000
Upfront and milestones payments included in contract liabilities	2,383	3,575
Revenue recognized from upfront and milestones payments	1,192	1,787	1,787
CRISPR
Notes to the Consolidated Statements of Operations
Upfront Payments Received Or Receivable	3,947			$ 4,500
Upfront and milestones payments included in contract liabilities	1,582	929
Revenue recognized from upfront and milestones payments	€ 770	€ 310	€ 310

X

- Definition

Represents of disclosure of notes to the consolidated financial statements.

+ References

No definition available.

+ Details

Name:	cvac_DisclosureOfNotesToConsolidatedFinancialStatementsLineItems
Namespace Prefix:	cvac_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of upfront payments of the company included in contract liabilities.

+ References

No definition available.

+ Details

Name:	cvac_UpfrontPaymentsIncludedInContractLiabilities
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of upfront payments received or receivable by the company.

+ References

No definition available.

+ Details

Name:	cvac_UpfrontPaymentsReceivedOrReceivable
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 116
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_GlaxosmithklineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_BoehringerIngelheimMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_GenmabMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MajorCustomersAxis=cvac_CrisprMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: